The last round trial of Corona vaccine - Covaxin may begin next month

The last round trial of Corona Vaccine Covaxin may begin next month. Bharat Biotech has got permission for Phase 3 trial from drug regulator. DCGI's expert committee met on Tuesday. In this, approval of the last trial of vaccine was given.

DCGI has 'slightly modified' the protocol. More than 25 thousand people are expected to participate in vaccine trials in India. They will be given two doses of vaccine at an interval of 28 days.

The results of the vaccine in the initial trial have raised hopes. Covaxin is the first indigenous corona virus vaccine. It has been created in association with the Indian Council of Medical Research (ICMR).

Bharat Biotech presented the Animal Challenge data along with the data for the first and second stage trials of the Corona vaccine. The company had said in its application that 28,500 people aged 18 or older would be included in this trial and this trial would be done at 19 places in 10 states of the country. This includes Delhi, Mumbai, Patna and Lucknow.

On October 5, the company's application was discussed by the Expert Committee of the Central Drugs Standard Control Organization.

The committee said in its recommendations that the study should be started with the appropriate dose identified based on the safety and immunological data of the second phase of testing.